114 related articles for article (PubMed ID: 2545208)
1. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
5. Lead- and calcium-mediated inhibition of bovine rod cGMP phosphodiesterase: interactions with magnesium.
Srivastava D; Hurwitz RL; Fox DA
Toxicol Appl Pharmacol; 1995 Sep; 134(1):43-52. PubMed ID: 7676457
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
7. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
Edwards JC; Ignarro LJ; Hyman AL; Kadowitz PJ
J Pharmacol Exp Ther; 1984 Jan; 228(1):33-42. PubMed ID: 6319670
[TBL] [Abstract][Full Text] [Related]
8. Uptake of CD-349 and nitrendipine into bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
J Pharmacobiodyn; 1989 Apr; 12(4):228-34. PubMed ID: 2795432
[TBL] [Abstract][Full Text] [Related]
9. cGMP-phosphodiesterase antagonists inhibit Ca2+-influx in Dictyostelium discoideum and bovine cyclic-nucleotide-gated-channel.
Lusche DF; Kaneko H; Malchow D
Eur J Pharmacol; 2005 Apr; 513(1-2):9-20. PubMed ID: 15878705
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
Cohen AH; Hanson K; Morris K; Fouty B; McMurty IF; Clarke W; Rodman DM
J Clin Invest; 1996 Jan; 97(1):172-9. PubMed ID: 8550830
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
12. Sodium nitroprusside alters Ca2+ flux components and Ca2(+)-dependent fluxes of K+ and Cl- in rat aorta.
Magliola L; Jones AW
J Physiol; 1990 Feb; 421():411-24. PubMed ID: 1693400
[TBL] [Abstract][Full Text] [Related]
13. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
[TBL] [Abstract][Full Text] [Related]
14. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cyclic GMP in the mode of action of a new antithrombotic agent PCA-4230; inhibition of the platelet cyclic GMP dependent phosphodiesterase.
Catalán RE; Martínez AM; Aragonés MD; Lombardía M
Thromb Res; 1997 Sep; 87(6):547-57. PubMed ID: 9330437
[TBL] [Abstract][Full Text] [Related]
17. Relaxation and cGMP formation in response to sildenafil and sodium nitroprusside in saphenous veins from normotensive and hypertensive patients.
Medina P; Segarra G; Martínez-León JB; Vila JM; Otero E; Lluch S
Am J Hypertens; 2002 Sep; 15(9):798-802. PubMed ID: 12219875
[TBL] [Abstract][Full Text] [Related]
18. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
20. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Gillespie PG; Beavo JA
Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]